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Abstract:  
Mitotic count (MC) is an important element for grading canine cutaneous mast cell 
tumors (ccMCTs) and is determined in ten consecutive high-power fields with the 
highest mitotic activity. However, there is variability in area selection between 
pathologists. In this study, the MC distribution and the effect of area selection on the 
MC were analyzed in ccMCTs. Two pathologists independently annotated all mitotic 
figures in whole-slide images of 28 ccMCTs (ground truth). Automated image analysis 
was used to examine the ground truth distribution of the MC throughout the tumor 
section area, which was compared with the manual MCs of 11 pathologists. 
Computerized analysis demonstrated high variability of the MC within different tumor 
areas. There were 6 MCTs with consistently low MCs (MC<7 in all tumor areas), 13 
cases with mostly high MCs (MC ≥7 in  ≥75% of 10-hpf-areas) and 9 borderline cases 
with variable MCs around 7, which is a cut-off value for ccMCT grading. There was 
inconsistency among pathologists in identifying the areas with the highest density of 
mitotic figures throughout the three ccMCT groups; only 51.9% of the counts were 
consistent with the highest 25% of the ground truth MC distribution. Regardless, there 
was substantial agreement between pathologists in detecting tumors with MC≥7. 
Falsely low MCs below 7 mainly occurred in 4/9 borderline cases that had very few 
ground truth areas with MC≥7. The findings of this study highlight the need to further 
standardize how to select the region of the tumor in which to determine the MC. 
 
Keywords: Area selection, high-power field, mitotic activity, mitotic figure distribution, 
tumor grading, tumor periphery. 
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Quantification of mitotic figures is one of the most common prognosticators of 
malignancy in veterinary and human tumor pathology.25,26 It is well accepted that higher 
numbers of mitotic figures are commonly associated with a more aggressive behavior 
of neoplasms.14,15,18,34,38,47 Accurate quantification of mitotic figures in standard 
histological sections stained with hematoxylin and eosin (HE) has been shown to have 
higher correlation to prognosis than a subjective impression by quick scanning in 
human breast cancer.39 Also for malignant neoplasms in veterinary pathology, it is 
recommended to routinely quantify mitotic activity by means of the mitotic count (MC), 
which is defined as the number of mitotic figures in ten consecutive non-overlapping 
high-power fields (hpf, field visible at 400x magnification with a field number of the 
ocular of FN=22, size is 2.37mm²).25 For some neoplasms, e.g., canine mast cell 
tumors (MCT),20,30,43 canine and feline mammary tumors,29,31 canine melanocytic 
tumors,42 or canine soft tissue sarcomas,13,24 the MC is also an important part of the 
tumor grading and cut-off values for the MC have been established that directly impact 
tumor grade. For example, the canine cutaneous MCT (ccMCT) grading developed by 
Kiupel et al.20 utilizes a cut-off value of seven mitotic figures in ten hpf as one of the 
criteria to grade ccMCTs. Former grading systems have used the cut-off value of MC 
of 10.11 Others have proposed prognostication of ccMCTs based entirely on the MC 
using a cut-off value of  5 or 7.15,32  
The MC is very applicable for routine surgical pathology and can be determined on 
glass and digital slides without any specialized equipment. Previous studies have 
shown that there is strong agreement in MC as determined by either light or digital 
microscopy in canine round cell tumors and human breast cancer.1,7 Nevertheless, the 
MC has some limitations in terms of inconsistency between observers. Several studies 
on human breast cancer1,9,12,27,28,44, canine mammary carcinomas36 and canine round 
cell tumors7 have shown that there is generally a high degree of inter-observer and 
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intra-observer variation of the MC. One of the most intensively discussed factors is the 
area unit ‘hpf’ which may vary up to 47% between different light microscopes at 400x 
magnification, depending on the field number (FN) of the respective ocular lens.6,25 
Surprisingly, many of the studies mentioned above did not define a ‘hpf’ beyond being 
the field of view at 400x magnification. A standard FN of 22mm with a subsequent area 
of a hpf at 400x magnification of 0.237mm2 has been proposed for veterinary pathology 
by Meuten et al.25. Similarly, when digital whole-slide images are viewed on a computer 
screen, the displayed area depends significantly on the monitor`s diagonal size.7,25 
Further attempts of standardization are to correct the MC by the proportion of 
neoplastic tissue within the hpf enumerated.12 Indeed, standardization of the area size 
has been shown to somewhat improve concordance of the MC as has been 
demonstrated in canine round cell tumors with an increase of the concordance 
correlation coefficient by 0.044 (non-standardized: 0.648; size-standardized: 0.692) 
and human breast cancer with an increase of the coefficient of variance of 3.7% (56.0% 
in the conventional method and 52.3% in the volume corrected method).7,12  
Another factor of influence is the difference between observers in their ability to identify 
individual mitotic figures and to distinguish them from other cell structures such as 
necrotic cells, especially in cases of prophase mitotic figures.23,27,44 Few studies in 
human breast cancer reported only slight to moderate inter-observer agreement (κ= 
0.13 - 0.57) or 6.9 – 54.5% disagreement on deciding whether an individual cell 
structure represents a mitotic figure or not.23,27,44 Appropriate sample fixation and slide 
preparation, including section thickness, are likely to have impact on mitotic figure 
identification.6 The influence of the viewing modality, i.e. light or digital microscopy, on 
identification of individual mitotic figures has not been fully assessed in veterinary or 
human pathology.  
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Importantly, selection of the evaluated hpf has been poorly standardized with vague 
selection criteria.4,44 Therefore, we hypothesized that variable area selection may be 
another factor influencing the MC regardless of the tumor type. Most grading systems 
as well as general recommendations request that mitotic figures should be counted in 
a single area comprised of 10 contiguous, non-overlapping hpf located in the tumor 
region with the highest mitotic activity.6,13,14,20,25,29,31,33,42,45,46 A tumor section with an 
area of 4.0 cm2 contains more than 1600 non-overlapping, standard-sized hpf. 
Therefore, scanning the tumor section and selecting the one area with the highest MC 
might be problematic.4,44 Some studies circumvented this problem by counting mitotic 
figures in randomly selected hpf.19,22,41 Other chose  the most cellular or most 
anaplastic part of the tumor as well as excluding areas with necrosis, hemorrhage and 
other artifacts.6,13,24,25 It is also recommended to perform the MC in the periphery of 
the tumor as this is the invasive front and the most optimally fixed material.6,25,26 
Although there is no systematic study in veterinary pathology to date, some authors 
have hypothesized that the potentially more aggressive tumor cells with possibly more 
proliferation are located at the invasive front of the tumor.25,37  
In this study, we hypothesized that mitotic figures are not randomly distributed in 
ccMCTs and that an arbitrary selection of the area enumerated will influence the MC. 
To test this hypothesis, two pathologists annotated all mitotic figures in whole-slide 
images of HE-stained tissue sections of 28 different ccMCTs. Consecutively, a self-
developed automated image analysis software was used to systematically analyze the 
distribution of mitotic figures throughout entire tumor sections (the software determined 
how many mitotic figures, which were labeled by two pathologists, were located in 
every possible 10-hpf-area of the tumor; we did not use artificial intelligence to identify 
mitotic figures). MCs performed manually by 11 anatomic pathologists were compared 
with the computerized ground truth MC distribution in order to determine how 
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successfully pathologists determine highest MCs. In addition, this study also tested the 
hypothesis that the density of mitotic figures is higher in the tumor periphery in 
comparison to the tumor center.  
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Material and methods 
Specimens 
Thirty-two ccMCTs, including 16 low-grade and 16 high-grade ccMCT (two-tier grading 
system according to original diagnosis; all high-grade cases had a MC ≥ 7),20 with 
acceptable tissue quality (determined by sufficient histological perceptibility of cellular 
details) were randomly selected from the authors’ archive. Subsequently, we excluded 
4 cases with tumor section areas of <12mm² from systematic analysis. These 4 ccCMT 
contained very few mitotic figures (1 –5 mitotic figures in the entire tumor section with 
a highest possible MC of 1 or 2) and, therefore, were considered inappropriate for 
calculating of MC distribution (exemplary heatmaps in Supplemental Figs. S1 and S2). 
MCTs had been formalin-fixed, sectioned along their largest and orthogonal diameter, 
and paraffin-embedded during routine diagnostic service. For this study we produced 
new tissue sections of a single representative tissue block per case, which were 
subsequently stained with hematoxylin and eosin (HE) by a tissue stainer (ST5010 
Autostainer XL, Leica, Germany). All slides were digitalized with a linear scanner 
(ScanScope CS2, Leica, Germany) in one focal plane by default settings at a scanning 
magnification of 400x, resulting in an image resolution of 0.25 µm per pixel. Largest 
histopathological tumor diameters of the 28 cases were measured in the whole-slide 
image by the ruler tool of the Aperio ImageScope© (Leica Biosystem Imaging) software 
and ranged from 5 mm to 28 mm (mean: 17.3 mm; Supplemental Table S1). Tumor 
diameters had to be determined form digitalized slides as gross measurements were 
not available for all cases. Statistical difference in largest tumor diameter between the 
later-defined three groups was calculated by a two-sided T-test by use of the SPSS 
Statistics 25 for Windows (IBM, New York, United States). 
 
Tumor area and mitosis annotation 
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The open source software package SlideRunner 2 was used for two annotation tasks 
(Fig. 1A). First, mitotic figures were labeled within the entire whole-slide image by two 
pathologists [CB, RK]. Initially, the complete slide was screened twice for all mitotic 
figures within the tumor section by the first pathologist [CB]. The screening was 
performed in a semi-automated manner, where the software would propose partly 
overlapping, consecutive image sections at a magnification of 400x to ensure that the 
entire whole-slide image was viewed thoroughly. As part of our annotation process, 
many of the non-mitotic cells (i.e. mast cells, eosinophils, and other cell structures such 
as apoptotic cells) were annotated as a different annotation class. We considered this 
an important approach in order to reduce confirmation bias for the second annotation 
task. The second pathologist [RK] was then asked to assign a second class, i.e. mitotic 
figure or non-mitotic cell, to all initially annotated structures, which were blinded to the 
cell class given by the first pathologist. This second opinion annotation was also 
performed in a semi-automated manner, where the software showed initial annotations 
that obscured the class previously assigned until all annotations on the slide had been 
given a second opinion. Both pathologists were instructed to only label convincing 
mitotic figures. Telophase figures with cytokinesis were labeled as a single mitotic 
figure. In total, 52,295 cell structures were annotated as mitotic figures by at least one 
of two pathologist in the 28 whole-slide images. Of those, 43,421 cells structures (83.0 
%) were agreed to be mitotic figures by both pathologists and were included in the 
ground truth data set for further analysis. Ground truth is a term for labeled data sets 
in image analysis that describes image information determined by the defined gold 
standard method, in this case the image location (coordinate) and annotation class (i.e. 
mitotic figure) of manual annotations agreed on by both pathologists. For the remaining 
8874 mitosis-annotations (17.0 %), the two pathologists disagreed on whether or not 
the cell structure was a mitotic figure and these annotations were disregarded for the 
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following study. Furthermore, a total of 152,866 annotations were labelled as non-
mitotic cell structures by consensus 
Second, the tumor section area within the whole tissue section was encircled by a 
single pathologist [CB] using a polygon annotation tool. This tumor area map included 
the entire tumor area and excluded necrotic areas, non-tumor-tissue within the tumor 
area larger than one hpf, such as a large blood vessel or entrapped residual tissue 
(sebaceous glands, hair follicles) and, in one case, a blurry image section (scanning 
artifact). In three cases (case 7, 16, and 22) there were areas within the tumor section 
area with variable cellularity. 
 
Generation of the mitotic count map 
Computerized image analysis was used to determine distribution of the manually 
labeled mitotic figures within the valid tumor area. For this purpose, different image 
maps were created from ground truth mitotic figure and tumor area annotations. First, 
a size-reduced digital map of the ground truth mitotic figure annotations was created 
using a downsampling factor of 32 (Fig. 1B). In this binary mitotic figure map, the center 
of each mitotic figure was assigned the value “1” and other coordinates the value “0”. 
The result was a map that included all single mitotic events at their respective 
downsampled coordinates with reduced computational complexity over the typically 
very large original whole-slide image dimensions.  
In a second step, we used a sliding window summation to assess the number of mitotic 
figures within a defined area in the slide. This tumor area was specified as a continuous 
region of adjacent ten standard-sized hpf with each spanning 0.237mm2 as 
recommended by Meuten et al..25 The resulting window covered a total area of 
2.37mm2 with an aspect ratio of 4:3 centered around the respective coordinates and a 
width/height of 1777.6/1333.2 microns, or approximately 7110/5333 pixels at original 
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scanning resolution, respectively. Downsampled as described above, the window was 
thus reduced to a size of 222 by 167 pixels. We decided to use the shape of a 4:3 
rectangle for the 10-hpf-area, as the viewing area of digital microscopy (computer 
screen) is rectangular, not round as for light microscopy. For each pixel position of the 
downsampled mitotic figure map, a frame of that defined size was centered on this 
pixel position and the sum of all mitotic figures within that frame was calculated. This 
sliding window summation yielded the mitotic count map that contained every possible 
mitotic count given an arbitrary center coordinate of the 10-hpf-area (Fig. 1C). In other 
words, a pixel of the mitotic count map represents the MC within the 10-hpf-area of 
which it is the center coordinate. Those steps described above have been replicated 
for defined areas of 20 hpf (4.74mm²), and 50hpf (11.85mm²).  
 
Generation of the valid tumor area map 
In a next step, a map of the valid tumor area in the tissue section was created as the 
region on the whole-slide image in which the MC derived from the mitotic count map 
had to be determined. We took the annotated area of tumor tissue on each slide and 
removed all exclusion image parts representing non-tumor tissue, necrotic tumor 
tissue, and blurry image regions. This resulted in a tumor area map, in which the entire 
tumor tissue was represented by the value “1”, and all non-tumor tissue by “0” (Fig. 
1D). The size of the tumor section area was determined from this map. The selected 
tumor sections had a mean tumor section area of 167.86 mm2 (range: 14.86 – 346.10 
mm²; standard deviation: 95.01 mm2; see Supplemental Table S1 for tumor size of 
individual sections).  
Subsequently, a derived valid tumor map was created that comprised all coordinates 
in which the center coordinate of the 10hpf, 20hpf, and 50hpf area was placed while 
covering tumor tissue (tumor area map) by at least 95% of the hpf-area (Fig. 1E). To 
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achieve this, we used a moving window averaging approach with a subsequent 
threshold of 0.95, effectively yielding a valid tumor map with reduced area over the 
initial tumor area map. 
 
Computerized analysis of the ground truth MC distribution 
For statistical analysis, all entries of the mitotic count map that were valid as per valid 
tumor area map were considered. Depending on the size of the valid tumor area, the 
total amount of 2.37mm² area windows evaluated varied from 57,665 to 4,185,973 
between the 28 cases (Supplemental Table S1). These numbers included all possible 
pixel-positions of the 2.37mm²-area window within the down-sampled valid tumor area 
that was determined by computerized calculation and used for the ground truth MC 
distribution. First, we computed the probability to arbitrarily select a high MC (MC ≥ 7) 
10-hpf-area; i.e. the number of the 10-hpf-areas that contained equal to or more than 
7 mitotic figures divided by all possible 10-hpf-areas within the valid tumor area (without 
exclusion tissue). The likelihood to select low MC areas (MC< 7) is the reciprocal of 
the indicated values. Based on that determined probability of the ground truth MC being 
above the cut-off value of 7, we defined 3 groups of ccMCTs (Fig. 2): 1) Group 1 (low 
MCs, n=6) has a 0% ground truth probability of a MC ≥ 7, i.e. all potential contiguous 
10-hpf-areas have MCs <7; 2). Group 2 (borderline cases, n=9) has a 0.01 – 74.99% 
probability of selecting an area with a MC above the cut-off value of 7, i.e. at least 
contains one 10-hpf-area with MC≥7; and 3) Group 3 (mostly high MCs, n=13) has a 
≥75% ground truth chance of arbitrarily selecting an area that has a MC ≥ 7, i.e. mostly 
comprises of 10-hpf-areas with MC≥7. Additionally, we similarly evaluated two further 
published cut-off values of 5, and 10.11,20,32 Secondly, we determined the regional 
variability of the mitotic count of each case by heat maps, box-and-whisker plots (see 
Supplemental Table S2 for minimum, 1st quartile, median, 3rd quartile and maximum 
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value), and histograms. Heat maps were generated by adding a semi-transparent 
green overlay to the microscopic image with the maximum value (as indicated by the 
color bar) having no transparency and the minimum value having full transparency 
(transparency is relative to the maximum MC). Box-and-whisker plots and histograms 
were generated with the python matplotlib 2.2.2 software. Effects of cellular density 
were determined subjectively based on the heat maps.  
 
 
Manual MC by pathologists 
Manual mitotic counts were obtained according to current guidelines by 11 board-
certified anatomic pathologists [AS, CG, DS, EN, MD, MK, OK, RK, RS, SC, TT; order 
of participants has been randomized for analysis] from four different diagnostic 
laboratories by examining the same digital images that were used for the ground truth 
data set. Pathologists were instructed to perform the MCs in the area with the highest 
mitotic density as requested by the current grading system to simulate a diagnostic 
setting.20 According to current recommendations, the number of required hpf was 
calculated for each pathologist in order to examine a total area of 2.37 mm², as the 
size of a hpf varies between different computer monitors.25 Presentation order of the 
28 cases was randomized. Pathologists were blinded to the tumor grade and the MCs 
of other pathologists. A total of 308 MC were available as a result of 11 pathologists 
examining all 28 cases (Supplemental Table S3). The MCs of the pathologists were 
categorized using the quartiles of the ground truth MC distribution. We chose a 
classification in favor of the pathologists by defining the categories as greater or equal 
than the lower bound quartile. Following this rule, the categories were defined as: 
Category 1 (MCs < 1st quartile), Category 2 (1st Quartile ≤ MCs < Median), Category 
3 (Median ≤ MCs < 3rd Quartile), Category 4 (3rd Quartile ≤ MCs). Low MC (group 1) 
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cases had a very narrow ground truth distribution with close to equal quartile cut-off 
values (discrete counts) and therefore category 4 may include significantly more than 
25% of the values. Categories 3 and 4 combined represent  the highest 50% of all 
possible ground truth MCs. Additionally, we categorized the MCs into below and above 
the cut-off value for ccMCT grading/prognostication.11,15,20,32 95% Confidence intervals 
(CI) were determined by the Wilson method with a continuity correction. Agreement for 
the high MC classification (MC ≥ 7) was evaluated by Light`s kappa (κ) for fully crossed 
designs and interrater agreement for the raw MC values of all pathologists was 
evaluated by intra-class correlation coefficient (ICC; two-way agreement, single-
measures, random). The k and ICC values are measures of the level of agreement 
corrected by chance between different participants; however, they do not indicate 
degree of accuracy to the ground truth. We evaluated kappa as poor = 0, slight = 0.01– 
0.20, fair = 0.21–0.40; moderate = 0.41–0.60, substantial = 0.61–0.80, or almost 
perfect = 0.81–1.00.17 ICC was evaluated as poor = 0 – 0.39, fair = 0.40 – 0.59, good 
= 0.6 – 0.74 and excellent = 0.75 – 1.00.17 Calculations were performed using R version 
3.52 (R Foundation, Vienna) using the package irr version 0.84.1.16 
 
Differences between tumor periphery and center 
Counting mitotic figures at the periphery of the tumor section has been recommended 
due to better fixation and suspected higher proliferation of tumor cells at the invasion 
front.25 For this reason, the ground truth mitotic activity index (MAI) was compared 
between the tumor periphery and center. MAI is defined as the number of mitotic 
figures within a tumor area, in this case tumor periphery or center, divided by the size 
(in mm2) of that respective area.25 As there is currently no consensus on the 
proportional and absolute size of the periphery in ccMCTs, we evaluated three different 
ratios of the tumor periphery containing 25%, 50%, and 75% of the total tumor area, 
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respectively. The tumor periphery was defined as the area between the tumor border 
margins, which was annotated by a single pathologist (see above), subtracted by the 
area of the tumor center, which was determined by step-wise reduction of the tumor 
area from the outside (erosion operator with uniform 3x3 filter kernel) until the target 
percentage of 75%, 50% and 25% (standard deviation: <0.15%) was reached. Tissue 
sections that contained wide-spread necrosis and ulceration, non-tumor tissue and 
scanning artifacts were excluded from calculation as described above. If the whole-
slide image comprised several tissue sections, area proportions were determined for 
the joint area of the sections and calculations of tumor size and MAI were added. 
Differences of the MAI between periphery and center for each defined proportion were 
tested for significance by a two-sided t-test with the python scipy version 1.1.0 stats-
package software. 
 
Results 
Probability of assigning high MC in arbitrary area selection 
The ground truth chances to arbitrarily select a tumor area that contains MCs above 
the cut-off value of MC ≥ 7  ranged from 0% to 99.97% (Supplemental Table S4). Group 
1 (always low MC, 0% chance) contained 6 ccMCTs (cases 1 – 6) and had the 
significantly (p≤ 0.003) smallest histopathological tumor diameters, ranging from 5 to 
16 mm (Median: 9.5mm; Fig. 3). Group 2 (borderline cases) included 9 ccMCTs with a 
very small (0.20 – 7.43%; case 7 – 10; subgroup 1) to moderate (26.48% – 73.97%; 
case 11 – 15; subgroup 2) ground truth chance of arbitrarily selecting a high MC area. 
In other words, these cases included few (subgroup 1; third quartile below 7) to 
numerous (subgroup 2, third quartile equal or greater 7) tumor areas with a MC ≥ 7 
and they included many tumor areas with a MC < 7. In group 2, largest 
histopathological tumor diameters ranged from 9 to 28 mm (median: 21 mm) and were 
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significantly (p= 0.003) larger than for group 1 MCTs, while two cases (case 9 and 10) 
had smaller tumor diameters than the maximum tumor diameter of group 1 MCTs (Fig. 
3). Group 3 (mostly high MC, ≥75% chance) comprised 13 ccMCTs (cases 16 – 28). 
In group 3, the largest tumor diameters of histopathological sections ranged from 7 to 
24 mm and were overall significantly (p= 0.002) larger than tumor diameters of group 
1 MCTs. However, three cases (cases 19, 21 and 25) overlapped with the tumor 
diameter range of group 1 MCTs (Fig. 3). Although in the majority of the cases the MC 
range  correlates with the tumor diameter, cases 19, 21 and 25 were noteworthy 
exceptions. 
 
Ground truth MC distribution  
Ground truth mitotic figures were irregularly distributed throughout the tumor section 
area for all groups, i.e. there were different MC depending on the tumor region 
assessed (Supplemental Figs. 1 and 2). Always-low MC cases (group 1) had MC 
ranges between 0 – 5 (Fig. 4 and 5). Therefore, area selection seems to be of minor 
importance in this group. Borderline cases (group 2; Fig. 6) had lower MC ranges in 
subgroup 1 between 7 – 13 (, Fig. 7) compared to subgroup 2 with MC ranges between 
30 – 108 (; Supplemental Fig. 3). In contrast to group 1, area selection seems to be 
essential in group 2. Mostly-high MC cases (group 3) had the highest ground truth MC 
between 28 and 335 (Fig. 8 and 9). In this group, random area selection would rarely 
lead to MCs below the cut-off value. Case 19 had an exceptionally narrow distribution 
and this tumor also had the smallest size. The present study included three ccMCTs 
with distinctly variable cellular density throughout the tumor section. Whereas in one 
case, the highest mitotic counts were in areas with high cellular density (case 18; 
Supplemental Fig. S4), another case had the highest activity in a region with low 
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cellular density (case 7; Supplemental Fig. S5). In the third case, cell-sparse regions 
had medium mitotic activity (case 22; Supplemental Fig. S6).  
By increasing the size of the area examined (10 hpf to 20 hpf and 50 hpf), the range 
of MC distribution (maximum and minimum) was generally mildly to moderately 
reduced (Supplemental Fig. 7-9), and the highest MC value was lowered to beneath 
the cut-off value in cases 7 to 10 (all cases of subgroup 1 from the borderline group). 
However, the median values largely remained unchanged.  
 
Pathologist’s Manual MC 
Overall inter-observer agreement of the manual MCs of eleven board-certified 
pathologists was good (ICC = 0.715; CI: 0.592 – 0.830). In comparison, ICC of group 
3 was smaller (ICC = 0.603; CI: 0.402 – 0.816) indicating that agreement on the highest 
values becomes more difficult with higher MC ranges. ICC of other groups are not 
indicated since the range of possible values was quite small and relative deviation was 
therefore overinflated (ICC values were quite small and should not be interpreted as 
such).  
Compared to the ground truth distribution, the manual MCs ranged from low to high 
values (Fig. 4, 6, 8). Of all manual counts of all pathologists, 74.4% (CI: 68.2 – 80.5%) 
were within the highest ≥50% (Category 3 and 4) of all ground truth MCs and 51.9% 
(CI: 42.6 – 61.6%) were within the highest ≥25% (Category 4) (Table 1, Supplemental 
Fig. S10). Manual MC of MCTs in group 3 were less often within the highest half 
(56.6%; CI: 44.8 – 68.9%) and quarter (36.4%; CI: 22.8 – 48.8%) of all possible ground 
truth MCs in comparison to group 1 (within highest half in 90.9%, CI: 81.2 – 95.9%; 
within highest quarter in 66.7%, CI: 53.2 – 79.0%) and group 2 (within highest half in 
88.9%, CI: 79.7 – 97.9%; within highest quarter in 64.6%, CI: 53.0 – 76.0%). When 
comparing the individual pathologists, there was high variability between MCs being 
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within the ground truth highest half ranging from 60.7 to 92.9%; (Fig. 10 and 
Supplemental Table S5) and highest quarter ranging from 32.1 to 82.1% (Fig. 11 and 
Supplemental Table S5). 
Additionally, we tested whether the manual MCs were above or below the grading cut-
off of 7 (Supplemental Fig. 11). Overall, there was substantial agreement between 
pathologists to detect high MCs above or equal 7 (κ= 0.865) for all cases combined. 
When comparing the three tumor groups, the MCs resulted consistently in a good 
prognosis and poor prognosis designation (based on the MC alone) for ccMCTs in 
groups 1 and group 3, respectively. However, for the borderline group, the MC was 
variable around the cut-off value, which would potentially impact the assigned grade. 
In low MC cases (group 1), the manual MCs were below 7 in 98.5% (CI: 91.6 – 99.8%; 
1.5% false positive) with only one overestimated count (case 4). In group 3 ccMCTs, 
pathologists determined MCs ≥ 7 with a detection rate of 96.5% (CI: 91.9 – 98.6%; 
mean ground truth chance in random area selection is 92.9%) with disagreement only 
in case 19, which had a very narrow distribution. Manual MC of borderline cases, which 
contained at least one area with MC ≥7 according to the ground truth distribution, were 
above the cut-off only in 53.5% (95.5-CI: 43.5 – 63.3%; mean ground truth chance in 
random area selection is 34.2%). In this group, underestimation of the MCs mainly 
occurred in subgroup 1, which had the cut-off value of 7 in the upper quartile of the 
ground truth distribution. Detection rate for MC ≥ 7 was 4.5% (CI: 1.1 – 16.4%; mean 
ground truth chance in random area selection is 2.9%). In contrast, pathologists had a 
detection rate of 92.7% (CI: 51.0 – 99.9%) for MC ≥ 7 for subgroup 2 cases (cases 11 
– 15; ground truth chance above 25%; mean is 59.2%); i.e. consistently reached cut-
off values.  
 
Usage of different cut-off values 
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We tested the influence of various published cut-off values, i.e.  5, MC ≥ 7 and MC ≥ 
10.11,15,20,32 Compared to the commonly used cut-off value of  7, we found considerable 
differences in the probability to assign a prognosis with cut-off values of  532 leading to 
a higher chance and the cut-off values  1011 leading to a lower chance of assigning a 
poor prognosis/outcome (Supplemental Fig. S11, S12 and Table S4). The influence 
was most significant in the borderline cases (group 2) with the greatest difference in 
chance between the cut-off values MC ≥ 5 and MC ≥ 10 being 42.56% in the most 
extreme case (tumor case 14; mean difference: 20.5%). In group 1, there was a mean 
difference of 0.04% (range: 0.00% - 0.18%) and in group 3, a mean difference of 9.09% 
(range: 0.28% - 38.66%). Similar effects were observed with the manual MCs 
performed by the 11 pathologists (Supplemental Table S4). Based on the manual MCs, 
borderline cases would have been assigned a high grade in 59.6%, 53.5%, and 33.3% 
(a difference of 26.3%) by the cut-off value of  5, 7, and 10, respectively. Therefore, 
the usage of different cut-off values resulted in relevant inter-observer variation for 
borderline cases. On the other hand, group 1 cases had a difference of only 1.5% 
(3.0%, 1.5%, and 1.5% probability, respectively) and group 3 cases had a difference 
of only 4.6% (97.9%, 96.5%, and 93.3% probability, respectively). As such, the cut-off 
value applied had minimal impact on inter-observer variation. 
 
Differences between the tumor periphery and center 
Computerized analysis was used to assess whether the ground truth mitotic density 
determined by the mitotic activity index (MAI, count of mitotic figures within the entire 
periphery or center area divided by the size of the area) varied between the periphery 
and center of the tumor area in the included ccMCTs. We defined the tumor periphery 
at three different sizes containing 25%, 50% or 75% of the entire tumor section area 
(Fig. 12). For a 25% periphery area ratio, the median MAI of the periphery was 2.65 
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mitotic figures/mm² and of the center was 4.55 mitotic figures/mm² (Fig. 13; for values 
of individual cases see Supplemental Table S6). In the case of the 50/50 area split, the 
median MAI was 3.60 mitotic figures/mm² and 4.68 mitotic figures/mm² for the 
periphery and center, respectively (Fig. 13; for values of individual cases see 
Supplemental Table S7). When the periphery contained 75% of the total valid tumor 
area, the median MAI of the periphery was 3.98 mitotic figures/mm² and of the center 
was 4.55 mitotic figures/mm² (Fig. 13; for values of individual cases see Supplemental 
Table S8). A two-sided t-test did not find a significant difference between the two 
groups for any of the three area proportions (p= 0.18, p= 0.48, and p=0.87, 
respectively). Results were similar between the three tumor groups. 
 
Discussion 
In order to standardize histopathological prognostication, several grading systems 
have been developed in veterinary pathology, all of which use the MC as one relevant 
parameter. An example is the two-tier grading system for ccMCT developed by Kiupel 
et al.20. This grading system uses the MC as one of four criteria to differentiate between 
aggressive high-grade and less aggressive low-grade MCT. Although the use of the 
MC, which is a seemingly objective absolute number, has increased the reproducibility 
of tumor grading systems, inter-observer inconsistency of the MC can potentially lead 
to variable prognostication. The area, in which the MC is performed, can only be hardily 
standardized potentially leading to inconsistency in prior studies and in routine 
diagnostics. In the present study, we however determined that the MC varies 
throughout ccMCT sections, which can potentially be explained by tumor 
heterogeneity. The MC varied among different regions of the tumor for those cases 
that had a high overall range of MCs (absolute variation). However, a relative regional 
MC variation was even higher for those cases with a small overall range of MCs, 
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although the absolute difference is small and likely of inferior clinical significance. This 
paradox needs to be considered when comparing agreement level (such as by the 
intra-class correlation coefficient) and this is why we decided to omit values for group 
1 and 2  Regardless of the high variability of the MC throughout the study, we found 
that prognostication of all 28 cases solely based on manual MCs by pathologists was 
very consistent when a cut-off of 7 was applied.15,20 High kappa values for grading 
indicated that all participating pathologists were able to perform in consensus with 
other pathologists, i.e. MCs were reproducible among the 11 board-certified 
pathologists. Only in a small subset of four borderline cases with very few ground truth 
areas having MC ≥7, the manual MCs commonly did not reach the cut-off values (i.e. 
false negative; these tumors were often incorrectly identified as having MC<7 based 
on manual counts by pathologists). Most manual MCs performed in the cases 
belonging to group 1, subgroup 2 of group 2 as well as group 3 were consistently below 
respectively above the cut-off value in agreement with the ground truth. Future studies 
are required to determine whether those ‘false negatives’ are truly low or high grade 
tumors. Borderline cases (group 2) were problematic and might potentially represent 
those cases where histopathological prognostication does not fit to the clinical 
outcome.  
 
The manual MC values of all pathologists had high variation being consistent with low 
to high mitotically active areas of the ground truth MC distribution. However, this high 
variability rarely impacted the prognostication based on current cut-off values.The 
upper quartile of the MC distribution (i.e. the MC in the mitotically most active tumor 
regions) was only reached in half of the cases; that is, pathologists’ manual counts 
tended to underestimate the highest MC based on the ground truth data. For group 3 
with the highest range of MCs, this was only true for one third of the manual MCs with 
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a 95% confidence interval that still included 25% (random chance). In addition, 
agreement of the 11 pathologists on the highest manual MCs was smaller for this group 
(group 3) in comparison to the overall agreement. Both findings indicate the difficulty 
in accurately and reproducibly performing the MC in cases with a high range of MCs 
and a potential large size of the histologic section.  
Results of the present study prove that manual MCs often do not represent the most 
mitotically active tumor regions and suggest that area selection likely has a significant 
influence on the MC. In addition, the high degree of variability of the MC could also be 
impacted by the degree of inter-observer variation in identifying mitotic figures. Such 
variation has been estimated to range from 6.9% to 54.5% by previous studies while 
the present study had a disagreement of 17%.23,27,44 Regardless, our study 
demonstrated that accurate and reproducible quantification of the most mitotically 
active region is hampered by marked inter-observer variation in digital slides.  
A limitation of the present study is that disease-free intervals and survival times were 
not available. Therefore, the direct influence of variable area selection and MCs on 
tumor prognosis could not be determined. However, it is the current scientific 
consensus that the most mitotically active region (and not the region with mean mitotic 
activity) correlates best with prognosis.26 Due to the moderate sensitivity of the current 
method in finding the most mitotically active area, the extent of correlation of the MC 
with disease outcome may have potentially been underestimated in previous studies. 
Further studies with large case numbers are required to verify whether the highest MC 
correlates best with clinical outcome.  
There is currently no appropriate recommendation to reliably find the mitotically most 
active region in ccMCTs. It has been proposed that the periphery of a tumor might be 
the mitotically more active region due to the location of the most aggressive tumor cells 
at the invasive front of the tumor.25,26 However, the present study found a minor but 
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statistically insignificant tendency towards a higher MC in the tumor center for all cases 
combined. However, individual cases were highly variable in whether the periphery or 
center of the tumor had higher MCs. These findings imply that the approach to count 
mitotic figures primarily in the tumor periphery would not  improve standardization of 
the MC in ccMCTs. Larger studies are essential to further evaluate whether the 
invasive front or the center of the tumor is a more reliable area than the periphery to 
determine the highest MC. It has also been reported that the MC should be counted in 
the most cellular regions in order to standardize the MC.6,13,25,46 In the present study, 
we included three cases with variable cellular density and in one case, the mitotically 
most active region was in an area of low cellularity. Although it seems conceivable that 
areas with lower cellularity may generally have a lower mitotic count, this may not be 
true for every case, and sometimes would have led to underestimation of the MC. Also, 
all current grading systems in veterinary pathology pay little attention to cellular density 
in terms of how the MC (a parameter independent of cellular density) is determined. In 
human breast cancer grading, a volume-corrected MC (MC divided by the estimated 
proportion of the hpf covered by tumor tissue) has been proposed;12 however, we 
speculate that proportion estimates are more difficult in round cell tumors with solitary 
tumor cells and often minimal tumor stroma. The number of mitotically active cancer 
cells can also be determined as the mitotic index (MI), which is the number of 
neoplastic cells with mitotic figures divided by the total number of neoplastic cells within 
a defined area.25 Although this parameter has been shown to be more reproducible 
than the mitotic count in some canine and feline tumors,37 it would be too laborious in 
a diagnostic setting to count all neoplastic cells in a 10 hpf area (in the authors’ 
experience there are often between 7,000 and 13,000 neoplastic cells in 10 hpf in a 
ccMCT). Future research will show if the MI can be implemented for routine diagnosis 
by the aid of computerized image analysis.  
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Selecting “crucial areas” in borderline cases seems very difficult. As discussed above, 
scanning the whole-slide image for the area with the highest mitotic density is quite 
ineffective especially in cases with a large range of MCs. One would assume that larger 
tumor sections may have higher a variability of the MC than smaller tumor sections 
simply based on the likelihood of such variations occurring more commonly in larger 
samples. In the present study, all tumor sections with a tumor diameter above 16 mm 
included areas with MC ≥ 7. Although MCTs with low MC in all regions (group 1) had 
a maximum largest tumor diameter of 16 mm, borderline MCTs (group 2) and MCTs in 
which most regions had high MCs (group 3) had maximum tumor diameters as small 
as 9 mm and 7 mm, respectively. Therefore, tumor diameters were independent of MC 
at least in some cases and probably are inaccurate for use as a solitary distinguishing 
feature. In some feline and canine neoplasms (feline cutaneous MCT;33 feline and 
canine mammary carcinoma;29,31 canine melanocytic neoplasia42), tumor size has 
indeed been determined to be a prognostic indicator. To the authors’ knowledge, 
similar systematic investigations have not been performed for canine cutaneous MCTs.  
Depending on the cut-off value used for tumor grading, the overall chance to assign a 
high grade based on the MC alone differed considerably in borderline cases. The three 
cut-off values applied (7, 5, and 10) have been used either as part of grading systems 
or as solitary prognostic parameters for ccMCT in previous studies.11,15,20,32 In contrast 
to previous grading approaches for ccMCT,11,30 the current grading system developed 
by Kiupel et al. 20 comprises only two grades.30 In the authors’ experience, some 
pathologists are more comfortable using a three-tier system that includes an 
intermediate grade regardless of the high prognostic and therapeutic uncertainty of the 
intermediate grade.35 However, as we define biological behavior by the presence or 
absence of invasion and metastatic spread, an intermediate grade has not yet been 
proven to give additional prognostic or therapeutic information in ccMCT.20,35 
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Borderline cases of the present study should not be classified as an intermediate 
grade, but rather as difficult cases that are prone to inconsistent MC determination 
around the cut-off value. There are always borderline cases between two distinct 
grades regardless of the number of different cut-offs applied. In fact, a three-tiered 
system has borderline cases between the 1st and 2nd grade as well as between the 2nd 
and 3rd grade, which might add further variability in grading in comparison to a two-
tiered system. The current results highlight the need to very carefully select the MC 
cut-off values when establishing a grading system as selection will have a great impact 
on borderline cases. In addition, it is likely that the MC cut-off value will have to be 
reevaluated with the development of methods that have higher sensitivity to find the 
most mitotically active region. 
 
A limitation of this study is that there is some inter-observer variation in histologically 
identifying individual mitotic figures. We tried to reduce this as much as possible for 
the ground truth data set by blinded labeling of two independent pathologists. While 
the inter-observer variability (17%) was relatively small in comparison to previous 
studies (27 - 37%), the variability is only based on two pathologists establishing the 
baseline data.23,27,48 The morphology of mitotic figures is defined as containing 
condensed chromosomes with hairy extension while lacking a nuclear membrane.26,46 
However, there are considerable differences in the morphology of mitotic figures 
depending on the phase of division as well as atypical morphologies and, therefore, 
discordance seems to be unavoidable to a certain degree. Even for well-trained 
pathologists it is difficult to differentiate mitotic figures from some apoptotic and 
pyknotic cells or overstained nuclei.23,27,44 In the present study, mitotic figures were 
annotated in the entire tissue section; however, large areas with necrosis were 
excluded in a second step. We also excluded labels that were not in concordance by 
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two pathologists as it has been recommended to only count unambigious mitotic 
figures.25 
The examination of whole-slide images scanned at a single focal plane may make it 
more difficult to identify mitotic figures because of the lack of fine focus and the limited 
image resolution.8 Although scanning at multiple focal planes (z-scanning) is 
technically available and allows the whole-slide image to be viewed at different levels 
comparable to the fine-focus of light microscopy, it is currently not used for routine 
diagnosis due to the extended scanning time and the huge file size of the whole-slide 
image.8 To reduce misidentification of mitotic figures, we also excluded all slides with 
inappropriate image quality, as mitotic figures are increasingly difficult to distinguish 
from artifacts such as overstained nuclei and necrosis throughout the entire slide.6 
Lastly, the specific tumor type, i.e. MCTs, may pose an additional challenge for 
identifying mitotic figures, as a large numbers of mast cell granules may mask nuclear 
details. Limited image resolution and lack of fine focus may have also affected area 
selection by pathologists for manual MCs as many participants noted additional 
difficulty in assessing the digital scans for mitoses in comparison to light microscopy.  
 
The present results emphasize the need for further standardization for area selection 
in order to achieve higher reproducibility in MC. As discussed above, variations in focal 
density of mitotic figures throughout the tumor section may pose a severe problem for 
area selection and subsequently for accurate counting. Improvement options include 
repeated counts by the same or different pathologists with the purpose of uniformity or 
to choose the highest count.13,25,26,29 Regardless of the increased time required, even 
various repeats would have only slightly increase the chance to find very rare events 
in the present cases. Alternatively, it has been proposed to increase the size of the 
area enumerated (for example to 20 hpf),10,27 which would also increase time 
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investment and therefore would be rather problematic in a diagnostic setting. Although 
the latter approach has been suspected to improve reproducibility of the MC by a 
computer model of human breast cancer,10 it would also change the MC towards the 
median value as demonstrated by the current study and, therefore, is inadequate to 
quantify the most mitotically active region. A new approach for standardization of the 
MC could be automated image analysis based on deep learning methods. 
Computerized analysis of a whole-slide image has the potential to reduce laborious 
tasks while minimizing inter-observer variability and maximizing reproducibility.8 
Several robust deep learning based algorithms have been developed to detect mitotic 
figures automatically in human breast cancer tissue,23,48,49 and similar systems are 
being investigated for ccMCT.3,4 However, fully automated mitotic activity estimations 
still have limitations for clinical applications as current algorithms do not have a high 
enough sensitivity and specificity (F1-score: 0.66 – 0.89).5,21 Therefore, algorithms are 
not necessarily better at identifying individual mitotic figures in comparison to 
pathologists; however, they may improve histopathological quantification of mitotic 
figures by investigating every pixel within the whole-slide images and therefore reduce 
area-selection bias. Subsequently, a potential way to standardize MCs by 
computerization is a fully automated preselection of the 10-hpf-area with the highest 
mitotic activity within the entire tumor section (field of interest) as has been shown 
recently.3,4 Future research has to determine to which degree a computer-assisted 
diagnosis system could support the pathologist’s task in tumor grading in a diagnostic 
situation. As the present study proposes that poor reproducibility of the MC can be 
explained to some degree by inconsistent area selection, we propose that determining 
the MC could significantly benefit from further attempts to standardize area selection. 
Nevertheless we acknowledge that representative MCs with high prognostic value are 
furthermore dependent on many other factors such as rapid tissue fixation.6 It is also 
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emphasized that further markers of cell proliferation (such as AgNOR and Ki-67) have 
excellent prognostic value and should be considered as supplemental methods for 
prognostication, especially in borderline cases.40  
 
In conclusion, the present study showed that in ccMCTs the MC may vary 
tremendously between different tumor areas. Pathologists were often unable to 
determine the area of the highest MC in whole-slide images, which is especially true 
for MCTs that had a high range of MCs throughout the tumor. Regardless, detection 
rate for current cut-off values of manual MCs were generally very reproducible between 
all pathologists. Inaccuracies in determining the highest MC was only problematic for 
prognostication in a subset of ccMCTs that contained few areas with ground truth MCs 
above the cut-off value. Our findings highlight the need for further standardization when 
quantifying mitotic figures in scanned slides of ccMCT. Computer-assisted diagnosis 
systems using automated image analyses and deep learning approaches might be a 
promising solution to accurately and reproducibly identify the area with the highest 
mitotic activity within large tumor sections.  
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Figure legends 
 
Figure 1. Overview of the processing chain to derive on-slide, ground truth mitotic 
count distribution from annotation data. A) Original whole-slide image of a canine 
cutaneous mast cell tumor (hematoxylin and eosin [HE], case 20, group 3) with mitotic 
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figure annotations (green dots) and tumor boundary annotations (solid red line). B) 
Downsampled (reduction of the resolution) mitotic figure map derived from the mitotic 
figure annotations. C) Mitotic count map representing the mitotic count determined 
within a defined area of 2.37mm² (i.e., 10 hpf) for every possible center coordinate 
within the whole-slide image. Brighter colors show higher mitotic counts. D) 
Downsampled, binary tumor area map derived from the tumor boundary annotations. 
E) Valid tumor area map derived from the tumor area map excluding tissue in which 
the center coordinate of the 10-hpf-area window would be covered less than 95% by 
tumor tissue. Original tumor boundary is depicted as a dashed red line. F) Combined 
visualization of the whole-slide image (HE), the mitotic count map within the original 
tumor area (green overlay; higher opacity equals a higher mitotic count), and the valid 
tumor area indicated by a black line. The center of each 10-hpf-area window was 
required to be within the black line. In this example the mitotic count ranges from 0 
(blue 10-hpf-area window) to 105 (red 10-hpf-area window).  
 
 
Figure 2 and 3. Comparison of the three canine cutaneous mast cell tumor groups 
which were defined as: group 1 (uniformly low mitotic count [MC]), group 2 (borderline, 
with subgroups 1 and 2), and group 3 (mostly high MC). Figure 2. Ground truth 
percentage of 10-hpf-areas with a MC ≥7 relative to the total number of all possible 10-
hpf-areas within the section. The three black broken vertical lines separate the defined 
groups and subgroups. The percentage of 10-hpf-areas with MC< 7 is the reciprocal 
of the indicated values. Figure 3. Comparison of the largest histopathological tumor 
diameter among the three tumor groups. The boxes show the first quartile, second 
quartile (median) and third quartile; the whiskers show the range (minimum and 
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maximum) of the data. There is a significant difference (p< 0.05) between group 1 and 
2 as well as group 1 and 3.  
 
 
Figure 4-9. Distribution of ground truth mitotic counts (MC) among 28 histopathological 
sections of canine cutaneous mast cell tumors. Figure 4, 6, and 8. Box-and-whisker 
plots (boxes show the first, second and third quartile; whiskers show the minimum and 
maximum of the data) of the ground truth MCs distribution of individual cases, divided 
into group 1 (uniformly low MCs; Figure 4), group 2 (borderline MCs; Figure 6) and 
group 3 (mostly high MCs; Figure 8). The cut-off value for tumor prognostication (MC 
≥ 7) is indicated by the red dashed line. Absolute numbers of the manual MC performed 
by eleven pathologists are indicated by the different symbols in the individual boxplots. 
Figure 5, 7, and 9. Exemplary cases of the three tumor groups including case 5 (Figure 
5; low MC), 9 (Figure 7, borderline) and 28 (Figure 9, mostly high MC). The images 
show the whole-slide image (hematoxylin and eosin) of the respective case with tumor 
border annotations (red lines) and the ground truth heat map of the MC as a green 
overlay with a MC range indicated by different opacity (scale on the right side). 
 
 
Figure 10 and 11. Forest plots of the manual mitotic count (MC) being above or equal 
to the upper half or upper 25%, respectively, of ground truth MC distribution comparing 
the eleven pathologists. Of each graph, the central symbol represents the result of the 
respective participant and the attached line represents the confidence interval (Wilson 
method with continuity correction). The left dotted lines demarcate the chance if the 
10-hpf-areas were selected randomly (50% and 25%, respectively) and the right line 
indicates the ideal achievement (100%). Figure 10. Forest-plot of the MC being above 
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or equal the ground truth median. Chance in fully random area selection would be 50%. 
Figure 11. Forest-plot of the MC being above or equal the ground truth third quartile. 
Chance in fully random area selection would be 25%.  
 
 
Figure 12 and 13. Comparison of the mitotic density between the tumor periphery and 
tumor center in 28 canine cutaneous mast cell tumors. Figure 12. Example of the three 
different definitions of the border between the tumor periphery and center in which the 
mitotic density was determined. Whole-slide image (hematoxylin and eosin) of case 22 
(mostly high MC) with the manually annotated tumor margins (red line). The blue line 
indicates the border circumscribing the periphery containing 25% and the center 
containing 75% of the total tumor area. The green line separates the tumor area in half. 
The cyan line marks the border between the 75% periphery area and the remaining 
25% center area. The green overlay superimposed on the whole-slide image indicates 
the mitotic count distribution with higher opacities representing higher mitotic counts 
(scale on the right side). Figure 13. Box-and-whisker plots (0-100% interval) of the 
mitotic density of the tumor center and periphery for all cases combined with three 
different size definitions. Mitotic density was determined by mitotic activity index, which 
was defined as the number of mitotic figures in a specific tumor area (i.e. tumor 
periphery and center) divided by the size of that area. Two-sided t-tests did not show 
significant differences between the two tumor areas for any of the three size definitions.  
 
